G. Steven Burrill

Welcome from the CEO

Flash required to view this video. Download the latest version here

 G. Steven Burrill 

Podcast

On this edition of The Burrill Report, Bodenheimer, a professor at the Center for Excellence in Primary Care in the Department of Family and Community Medicine at the University of California, San Francisco, discusses why we must address the crisis in primary care for healthcare reform to succeed. 
Hear the podcast 

News

Biotech buoyed by strong capital market performance in second quarter July 01, 2009 | Press Release

Shawn Cross Joins Burrill Merchant Banking June 16, 2009 | Press Release

Biotech shows glimmer of an upward trend June 01, 2009 | Press Release

  See all News
 
Sign up to receive email notifications about our upcoming events and news.


Sign up for a free subscription to The Burrill Weekly Brief 
Burrill Media is the creator, sponsor and facilitator of over a dozen leading industry conferences worldwide and publishes a wide range of bio-intelligence reports. Annual conferences include The Biotech Meeting, The Indiana Life Sciences Forum, The Burrill Personalized Medicine Meeting, The Aging Meeting and The Stem Cell Meeting. Burrill Media publications  include the annual State of the Industry, The Personalized Medicine Report, The Stem Cell Report, and periodic newsletters covering Canada, China, Europe, India, Japan and Partnering/M&A. Burrill also publishes The Burrill Report, a bimonthly magazine.

The Burrill Report

The Burrill Report May 2009: Single Issue May 2009: Q1 2009 Global Industry Analysis, plus Stem Cell & Regenerative Medicine Feature › Learn More


Add to cart$595.00

 

The Burrill Report November 2008: Single Issue Personalized medicine has the power to transform health care within the foreseeable future, and is already having a disruptive impact on the U.S. health care system. This issue looks at the latest developments and complements our Personalized Medicine Report, published separately. › Learn More


Add to cart$299.00

 

The Burrill Report October 2008: Single Issue In the past, biotechs have recovered from several “nuclear winters” as the financial markets rebounded from their various perturbations. This time the problem lies in the very sustenance of the industry-capital, which has been its umbilical cord since the industry’s inception. Now that cord has been cut and we are entering a very different world where capital will be more expensive and difficult to obtain. This issue looks at the ramifications of this scenario. › Learn More


Add to cart$299.00

The Burrill Report August/September 2008: Single Issue In this launch issue, we provide biotech’s report card the first half of 2008, with detailed analysis and data on biotech financings and deal activity, public company financials, and important scientific advances. We also introduce our biotech surveys feature on "Personalized Medicine and Wellness." › Learn More


Add to cart$299.00

  

The Burrill Report Excerpt August/September 2008: CEO Interview, Free with Registration Every issue, BBR will be publishing an “in depth” interview with a Biotech company CEO. We are extremely pleased to kick off this feature with George Scangos, CEO of Exelixis, who paints a very sobering picture of today’s turbulent economic climate and its impact on the biotech industry: With investors in risk-avoidance mode and demanding later and later data on lead products before they invest, where will the cash come from to conduct later trials in order to satisfy these demands? › Learn More